Afuco™ Anti-Human CSPG4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CSPG4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies bind to the membrane-proximal domain (MP) of human Melanoma-Associated chondroitin Sulphate Proteoglycan (MCSP), and are capable of mediating cytolysis of a cell expressing MCSP in the presence of human effector cells or complement. They can be used to treat for the immunotherapy of melanoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-182CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CSPG4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |